Abstract
Membranous nephropathy (MN) may occur in the transplanted kidney, either as recurrent disease in patients who had MN as the cause of end-stage renal disease (ESRD) in the native kidney or de novo, in patients who had another cause of ESRD initially. The reported incidence of recurrent MN ranges between 10% and 45%. Clinical manifestations of recurrent MN are typically observed 13-15 months after transplantation, although they may be observed much earlier (within weeks). Our patient had a recurrence in three weeks. Recurrent disease can lead to loss of the allograft.
Cite
CITATION STYLE
Kumar, A. N., Murlidharan, P., Patil, S., Balan, S., & Ramdas, P. (2018). Recurrence of membranous nephropathy three weeks’ postrenal transplant: A surprise in store. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 29(3), 705–708. https://doi.org/10.4103/1319-2442.235186
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.